Key result
Adipose-derived extracellular vesicle miRNAs play a key role in regulating white adipose tissue browning, insulin resistance, diabetes, and inflammation in obesity.
Adipose-derived EV miRNAs play a significant role in regulating metabolic processes and may offer new avenues for understanding and treating obesity-related metabolic diseases.
Should not yet change obesity care; leaves open therapeutic targeting of adipose EV miRNAs pending trials.
Obesity and its associated metabolic diseases, including diabetes, insulin resistance, and inflammation, are rapidly becoming a global health concern. Moreover, obese individuals are more likely to be infected with COVID-19. New research on adipose tissue is required to help us understand these metabolic diseases and their regulatory processes. Recently, extracellular vesicles (EVs) have been identified as novel intercellular vectors with a wide range of regulatory functions. The miRNAs carried by EVs participate in the regulation of white adipose tissue (WAT) browning, insulin resistance, diabetes, and inflammation. In addition, EV miRNAs demonstrate great potential for helping elucidating the mechanism of metabolic diseases, and for advancing their prevention and treatment. In this review, we focus on the mechanisms underlying the regulation of adipose differentiation and metabolic diseases by adipose-derived EV miRNAs. Understanding the role of these miRNAs should enrich our understanding of the etiology and pathogenesis of metabolic diseases caused by obesity.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2021) conducted a review in Obesity and associated metabolic diseases. Adipose-derived extracellular vesicle miRNAs was evaluated. Adipose-derived extracellular vesicle miRNAs play a key role in regulating white adipose tissue browning, insulin resistance, diabetes, and inflammation in obesity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: